Maura Corsetti
Overview
Explore the profile of Maura Corsetti including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
95
Citations
1474
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Lindsell H, Williams N, Magistro D, Corsetti M, Walton G, Hunter K
Neurogastroenterol Motil
. 2025 Mar;
:e70004.
PMID: 40026117
Background: Irritable bowel syndrome (IBS) is one of the most prevalent gastrointestinal (GI) disorders worldwide. Defined as a disorder of gut-brain interaction, its pathophysiology is still not completely clear. Consequently,...
2.
Butt M, Isherwood G, Lewis-Lawson T, Sbarigia C, Lambiase C, Aburumman R, et al.
Neurogastroenterol Motil
. 2025 Feb;
:e15019.
PMID: 40017096
Introduction: The prevalence of opioid use and its impact on healthcare outcomes among patients with Rome IV functional dyspepsia (FD) has not been reported in real-world clinical practice in the...
3.
Butt M, Cefalo F, Sbarigia C, Dhali A, Corsetti M
Neurogastroenterol Motil
. 2025 Feb;
:e70007.
PMID: 40017095
Background: Central neuromodulators, specifically tricyclic antidepressants (TCAs), are prescribed as prophylactic treatment for cyclical vomiting syndrome (CVS). It is unclear whether opioids and/or cannabis affect the treatment response to neuromodulators....
4.
Manthopoulou E, Catalan-Serra I, Corsetti M, Nowak A, Perugorria M, Simsek C, et al.
United European Gastroenterol J
. 2025 Feb;
PMID: 39949291
This review highlights gender gaps in training, career, and work-life balance in gastroenterology. Stereotypes and biases toward women's abilities and commitment to their careers can influence evaluations, advancement in gastroenterology...
5.
Traserra S, Appelqvist T, Lange R, Corsetti M, Jimenez M
Br J Pharmacol
. 2025 Feb;
PMID: 39947210
Background And Purpose: Hyoscine butylbromide (HBB) has a low oral (PO) bioavailability. Further, limited data on its activity on non-gastrointestinal (GI) smooth muscle spasms after oral dosing are available, causing...
6.
Malagelada C, Keller J, Sifrim D, Serra J, Tack J, Mulak A, et al.
United European Gastroenterol J
. 2025 Jan;
PMID: 39754724
Introduction: Chronic nausea and vomiting are symptoms of a wide range of gastrointestinal and non-gastrointestinal conditions. Diagnosis can be challenging and requires a systematic and well-structured approach. If the initial...
7.
Alhasani A, Modasia A, Anodiyil M, Corsetti M, Aliyu A, Crooks C, et al.
J Nutr
. 2024 Dec;
155(3):839-848.
PMID: 39732438
Background: Recent studies show that the increase in breath hydrogen (BH) and symptoms after ingestion of inulin are reduced by coadministering psyllium (PI). Objectives: To determine if slowing delivery of...
8.
Aliyu A, Dellschaft N, Hoad C, Williams H, Gaudoin E, Sulaiman S, et al.
Clin Pharmacol Ther
. 2024 Dec;
PMID: 39679695
Bisacodyl is a widely used laxative that stimulates both motility and secretion. Our aim was to exploit the unique capabilities of MRI to define bisacodyl's mode of action. Two placebo-controlled...
9.
Butt M, Corsetti M
Aliment Pharmacol Ther
. 2024 Nov;
61(2):392-393.
PMID: 39543836
No abstract available.
10.
Wilkinson-Smith V, Scott M, Menys A, Wiklendt L, Marciani L, Atkinson D, et al.
Gut
. 2024 Oct;
74(1):35-44.
PMID: 39438126
Background: Colonic motility in constipation can be assessed non-invasively using MRI. Objective: To compare MRI with high-resolution colonic manometry (HRCM) for predicting treatment response. Design: Part 1: 44 healthy volunteers...